 NRx Pharmaceuticals Inc NASDAQ: NRXP has signed an agreement with Cardinal Health Inc NYSE: CAH to provide third-party logistics and distribution of Zyesami upon the potential FDA Emergency Use Authorization EUA approval. In May, NRx applied for EUA to the FDA for Zyesami aviptadil for critical COVID-19 patients with respiratory failure. 